Author

M. Cusnir

Observed name: Cusnir, M.

Institution: Mount Sinai Medical Center

Observed institution: Mount Sinai Medical Center

OpenAlex ID: A5060812437

802P Nous-209 immunotherapy with pembrolizumab for microsatellite instability high (MSI-H) metastatic colorectal cancer, refractory to anti-PD-1: Phase II trial results

2025 · F.J. Ros Montana, E. Elez Fernandez, et al. · Annals of Oncology

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

2020 · Cohen, D. J., Jimeno, A., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)

Works count: 2

Citation count:

H-index:

I10-index: